Research Topics
Species | Joseph MonsonegoSummaryAffiliation: Institut Alfred Fournier Country: France Publications
| Collaborators
|
Detail Information
Publications
Cervical cancer control, priorities and new directionsJoseph Monsonego
EUROGIN, Paris, France
Int J Cancer 108:329-33. 2004..We report the conclusions of the Experts' Meeting at the EUROGIN 2003 conference...- Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smearJoseph Monsonego
Institut Alfred Fournier, 25 Boulevard St Jacques, 75014 Paris, France
Int J STD AIDS 19:385-92. 2008..6%) with high NPV (98.9%) in detecting CIN3+ lesions. HPV16 genotyping alone significantly improves SP and PPV of this test in management of women with abnormal cytology... - Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array testsJoseph Monsonego
Institut Alfred Fournier Paris, France
Sex Transm Dis 35:521-7. 2008..To assess the concordance and performance of 2 different assays in detection of human papillomavirus (HPV) genotypes among women with abnormal Pap smear... - P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smearJoseph Monsonego
Alfred Fournier Institute, Paris, France
Acta Cytol 51:755-66. 2007..To test whether p1l6(INK4a) immunocytochemistry (ICC) in liquid-based cytology (LBC) is useful with colposcopy in abnormal Pap smears... - [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France]J Monsonego
Institut Fournier, 174, ruedeCourcelles, 75017 Paris, France
Gynecol Obstet Fertil 35:107-13. 2007..The objectives of this study were to estimate the incidence of genital warts and treatment costs in women consulting gynaecologists in France in 2005... - Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasiaJ Monsonego
Institut Alfred Fournier, Paris, France
Int J Gynecol Cancer 16:591-8. 2006..High viral load (>100 relative light unit/positive control) was associated with significant disease. HPV DNA testing improves the accuracy of colposcopy in the detection of high-grade CIN in women with ASCUS or LSIL smears... - [Colposcopy: the value of HPV testing in clinical practice]J Monsonego
Département de colposcopie, Institut Alfred Fournier, Paris, France
Gynecol Obstet Fertil 32:62-74. 2004..Therapeutic decisions must not be based solely on the results of HPV DNA testing except in specific cases... - Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smearJoseph Monsonego
Institut Alfred Fournier, 25 Boulevard St Jacques, 75014 Paris, France
Gynecol Oncol 99:160-8. 2005..To assess the performance of a novel PCR-based assay (Roche AMPLICOR HPV test) in detection of cervical pathology as a part of management for abnormal PAP smear (MAPS) and in women participating in cervical cancer screening... - [Cervical cancer prevention: the impact of HPV vaccination]J Monsonego
Institut A Fournier, 174, rue de Courcelles, 75017 Paris, France
Gynecol Obstet Fertil 34:189-201. 2006..Cervical cancer screening strategies, that will be cost-effective for the proper surveillance of women protected by HPV vaccination, are under analysis... - Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study)Joseph Monsonego
Institut of the Cervix, Paris, France
Gynecol Oncol 125:175-80. 2012..To assess the performance of (FDA-approved) APTIMA® HPV Assay (AHPV), Hybrid Capture 2 (HC2), in-house PCR genotyping, and ThinPrep LBC in population-based screening, stratified by three histological gold standards... - Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE studyJoseph Monsonego
Institute of the Cervix, Federation Mutualiste Parisienne, Paris, France
Int J Cancer 129:691-701. 2011..AHPV assay is both specific and sensitive for the detection of high-grade precancerous lesions and may be considered as an option for routine cervical cancer screening for women over 20 years of age... - [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues]Joseph Monsonego
Institut Alfred Fournier, Paris
Presse Med 36:640-66. 2007..Vaccination and screening, which are complementary and synergistic, now constitute the new standards for prevention of this disease... - [Prevention of cervical cancer: screening, progress and perspectives]Joseph Monsonego
Institut Alfred Fournier, Paris
Presse Med 36:92-111. 2007..The impending availability of prophylactic HPV vaccines, which are expected to provide 70% protection against cervical cancer, will not affect the practice of screening, which must continue... - Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countriesJoseph Monsonego
Institut of the Cervix, 174 rue de Courcelles, 75017 Paris, France
BMC Womens Health 11:18. 2011..We investigated current practices of communicating abnormal Pap results to evaluate women's reactions and determine the sources of information they use subsequently... - Civil society: a critical new advocate for vaccination in EuropeVanina Laurent-Ledru
MSD, Paris, France
Vaccine 29:624-8. 2011..The successful implementation and sustainability of future vaccination programs against infections such as HIV will be dependent upon the active participation of civil society to inform, to reassure and to maintain public trust... - EUROGIN 2007 patient education conference: sharing experiences and action in cervical cancer prevention--an overview. Part 2Sonia Pagliusi
Centers for Disease Control, Atlanta, USA
Vaccine 26:A33-6. 2008